CLOV Q3 Estimates Unchanged Before Earnings: How to Play the Stock?

Clover Health Investments, Corp. (CLOV) is scheduled to report third-quarter 2024 results on Nov. 6, after the closing bell.In the last reported quarter, the company delivered earnings per share of a penny against the Zacks Consensus Estimate of a loss of 4 cents. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on each of the four occasions, delivering an earnings surprise of 49.2%, on average.For third-quarter 2024, the Zacks Consensus Estimate for revenues is pegged ...